Using data from Crunchbase and PitchBook, TechCrunch tracked down the VC-backed startups that became unicorns so far this ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Discover the best gummy vitamins recommended by dietitians and what to look for when choosing a high-quality supplement you’ll actually enjoy.

Heat-resilient biofertilizers could help crops cope with rising temperatures but engineering them has been slow and uncertain ...

Researchers from Skoltech, MEPhI, and the Dukhov All-Russian Research Institute of Automation have proposed a new method to ...

Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...

Floquet control uses time-periodic drives to engineer quantum systems, creating dynamic changes in material properties ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...